Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N U Bang

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
Trends in Cardiovascular Medicine|January 18, 2011
Antithrombotic agents from salivary glands of hematophagous animalsN U Bang, M D Clayman
Thrombosis and Haemostasis|December 15, 1977
Serine protease specificity for peptide chromogenic substratesL E Mattler, N U Bang
Haemostasis|January 1, 1978
Sensitivity and specificity of plasma serine protease chromogenic substratesN U Bang, L E Mattler
The Journal of Laboratory and Clinical Medicine|February 1, 1992
What molecular biology has taught us about fibrinolysisO G Wilhelm, N U Bang
Molecular and Cellular Biochemistry|April 2, 1979
Plasma protein regulation of platelet function and metabolismM S Hansen, N U Bang
Biochemistry|August 1, 1972
Formation of soluble fibrin polymers. Fibrinogen degradation fragments D and E fail to form soluble complexes with fibrin monomerG F Smith, N U Bang
Kidney International|April 1, 1988
Analysis of the plasminogen activator activity of the human glomerulusJ M Bergstein, M Riley, N U Bang
The New England Journal of Medicine|September 10, 1992
Role of plasminogen-activator inhibitor type 1 in the pathogenesis and outcome of the hemolytic uremic syndromeJ M Bergstein, M Riley, N U Bang
The American Journal of Medicine|September 1, 1982
Plasma inhibitor of glomerular fibrinolysis in the hemolytic-uremic syndromeJ M Bergstein, U Kuederli, N U Bang
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|July 1, 1993
Recombinant human thrombomodulin attenuates human endothelial cell activation by human thrombinJ F Parkinson, N U Bang, J G Garcia
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Trends in Cardiovascular Medicine|January 18, 2011
Antithrombotic agents from salivary glands of hematophagous animalsN U Bang, M D Clayman
Thrombosis and Haemostasis|December 15, 1977
Serine protease specificity for peptide chromogenic substratesL E Mattler, N U Bang
Haemostasis|January 1, 1978
Sensitivity and specificity of plasma serine protease chromogenic substratesN U Bang, L E Mattler
The Journal of Laboratory and Clinical Medicine|February 1, 1992
What molecular biology has taught us about fibrinolysisO G Wilhelm, N U Bang
Molecular and Cellular Biochemistry|April 2, 1979
Plasma protein regulation of platelet function and metabolismM S Hansen, N U Bang
Biochemistry|August 1, 1972
Formation of soluble fibrin polymers. Fibrinogen degradation fragments D and E fail to form soluble complexes with fibrin monomerG F Smith, N U Bang
Kidney International|April 1, 1988
Analysis of the plasminogen activator activity of the human glomerulusJ M Bergstein, M Riley, N U Bang
The New England Journal of Medicine|September 10, 1992
Role of plasminogen-activator inhibitor type 1 in the pathogenesis and outcome of the hemolytic uremic syndromeJ M Bergstein, M Riley, N U Bang
The American Journal of Medicine|September 1, 1982
Plasma inhibitor of glomerular fibrinolysis in the hemolytic-uremic syndromeJ M Bergstein, U Kuederli, N U Bang
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|July 1, 1993
Recombinant human thrombomodulin attenuates human endothelial cell activation by human thrombinJ F Parkinson, N U Bang, J G Garcia
Pageof 7